Back to search
FDAFDA · Food and drugs·Recall number D-0356-2025

Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41

Published April 16, 2025 · Recall initiated: March 21, 2025

Summary

FDA records drug Class II recall D-0356-2025, published April 16, 2025 and initiated March 21, 2025. Recalling firm: Somerset Therapeutics Private Limited; Status: Ongoing; Reported quantity: 4956 vials; Lot: A240467B, exp. date 07/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Media fill with bacterial contamination

What to do

Voluntary: Firm initiated · Letter

Get an email if HALOPERIDOL DECANOATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HALOPERIDOL DECANOATE
Manufacturer
Somerset Therapeutics Private Limited
Distributor
U.S. Nationwide
UPC
0368001578592
Lot
A240467B, exp. date 07/2026
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41 recalled?

Yes. FDA published recall D-0356-2025 on April 16, 2025. Reported hazard: Lack of Assurance of Sterility: Media fill with bacterial contamination

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HALOPERIDOL DECANOATE. UPC: 0368001578592.